TYK2
Non-receptor tyrosine-protein kinase TYK2
Also known as: JTK1, TYK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29597
- Gene
- TYK2
- Ensembl
- ENSG00000105397
- Chromosome
- 19
- Canonical length
- 1187 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also a component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with Immunodeficiency 35. [provided by RefSeq, Sep 2020]
Canonical amino-acid sequenceUniProt
1187 residues, UniProt reviewed canonical sequence.
>P29597|TYK2
1 MPLRHWGMAR GSKPVGDGAQ PMAAMGGLKV LLHWAGPGGG EPWVTFSESS LTAEEVCIHI
61 AHKVGITPPC FNLFALFDAQ AQVWLPPNHI LEIPRDASLM LYFRIRFYFR NWHGMNPREP
121 AVYRCGPPGT EASSDQTAQG MQLLDPASFE YLFEQGKHEF VNDVASLWEL STEEEIHHFK
181 NESLGMAFLH LCHLALRHGI PLEEVAKKTS FKDCIPRSFR RHIRQHSALT RLRLRNVFRR
241 FLRDFQPGRL SQQMVMVKYL ATLERLAPRF GTERVPVCHL RLLAQAEGEP CYIRDSGVAP
301 TDPGPESAAG PPTHEVLVTG TGGIQWWPVE EEVNKEEGSS GSSGRNPQAS LFGKKAKAHK
361 AVGQPADRPR EPLWAYFCDF RDITHVVLKE HCVSIHRQDN KCLELSLPSR AAALSFVSLV
421 DGYFRLTADS SHYLCHEVAP PRLVMSIRDG IHGPLLEPFV QAKLRPEDGL YLIHWSTSHP
481 YRLILTVAQR SQAPDGMQSL RLRKFPIEQQ DGAFVLEGWG RSFPSVRELG AALQGCLLRA
541 GDDCFSLRRC CLPQPGETSN LIIMRGARAS PRTLNLSQLS FHRVDQKEIT QLSHLGQGTR
601 TNVYEGRLRV EGSGDPEEGK MDDEDPLVPG RDRGQELRVV LKVLDPSHHD IALAFYETAS
661 LMSQVSHTHL AFVHGVCVRG PENIMVTEYV EHGPLDVWLR RERGHVPMAW KMVVAQQLAS
721 ALSYLENKNL VHGNVCGRNI LLARLGLAEG TSPFIKLSDP GVGLGALSRE ERVERIPWLA
781 PECLPGGANS LSTAMDKWGF GATLLEICFD GEAPLQSRSP SEKEHFYQRQ HRLPEPSCPQ
841 LATLTSQCLT YEPTQRPSFR TILRDLTRLQ PHNLADVLTV NPDSPASDPT VFHKRYLKKI
901 RDLGEGHFGK VSLYCYDPTN DGTGEMVAVK ALKADCGPQH RSGWKQEIDI LRTLYHEHII
961 KYKGCCEDQG EKSLQLVMEY VPLGSLRDYL PRHSIGLAQL LLFAQQICEG MAYLHAQHYI
1021 HRDLAARNVL LDNDRLVKIG DFGLAKAVPE GHEYYRVRED GDSPVFWYAP ECLKEYKFYY
1081 ASDVWSFGVT LYELLTHCDS SQSPPTKFLE LIGIAQGQMT VLRLTELLER GERLPRPDKC
1141 PCEVYHLMKN CWETEASFRP TFENLIPILK TVHEKYQGQA PSVFSVCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TYK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 101 nTPM
Expression across tissuesHPA
Tissue
- spleen: 101 nTPM
- liver: 90 nTPM
- kidney: 61 nTPM
- heart muscle: 50 nTPM
- pituitary gland: 48 nTPM
- lung: 46 nTPM
Single-cell type
- neutrophils: 141 nCPM
- monocytes: 57 nCPM
- neutrophil progenitors: 52 nCPM
- cdc: 51 nCPM
- monocyte progenitors: 50 nCPM
- kupffer cells: 40 nCPM
Immune cell
- myeloid DC: 14 nTPM
- eosinophil: 12 nTPM
- classical monocyte: 11 nTPM
- neutrophil: 11 nTPM
- non-classical monocyte: 11 nTPM
- total PBMC: 9.1 nTPM
Brain region
- medulla oblongata: 10 nTPM
- choroid plexus: 9.6 nTPM
- midbrain: 8.4 nTPM
- cerebral cortex: 8.1 nTPM
- spinal cord: 8 nTPM
- thalamus: 8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TYK2.
Disease | AllUniProt
Conditions TYK2 is implicated in, by any mechanism.
- Immunodeficiency 35 (IMD35) MIM:611521
Disease | GeneticClinVar
46 pathogenic / likely-pathogenic of 1,126 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 35
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cell population proliferation
- cell surface receptor signaling pathway via JAK-STAT
- cellular response to virus
- cytokine-mediated signaling pathway
- growth hormone receptor signaling pathway via JAK-STAT
- immune response
- interleukin-10-mediated signaling pathway
- interleukin-12-mediated signaling pathway
- interleukin-23-mediated signaling pathway
- intracellular signal transduction
- positive regulation of interleukin-17 production
- positive regulation of natural killer cell proliferation
- positive regulation of NK T cell proliferation
- positive regulation of protein localization to nucleus
- positive regulation of receptor signaling pathway via JAK-STAT
- positive regulation of T cell proliferation
- positive regulation of T-helper 17 type immune response
- positive regulation of type II interferon production
- protein phosphorylation
- type I interferon-mediated signaling pathway
- type II interferon-mediated signaling pathway
- type III interferon-mediated signaling pathway
Molecular functions
- ATP binding
- growth hormone receptor binding
- non-membrane spanning protein tyrosine kinase activity
- protein tyrosine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FERM domain
- Protein kinase domain
- SH2 domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Tyrosine-protein kinase, non-receptor Jak/Tyk2
- Protein kinase, ATP binding site
- Band 4.1 domain
- Tyrosine-protein kinase, catalytic domain
- FERM superfamily, second domain
- SH2 domain superfamily
- JAK, FERM F2 lobe domain
- FERM F1 lobe ubiquitin-like domain
- JAK1-3/TYK2, pleckstrin homology-like domain
- Janus Kinase (JAK)
- Protein tyrosine and serine/threonine kinase
- Jak1 pleckstrin homology-like domain
- FERM F2 acyl-CoA binding protein-like domain
- FERM F1 ubiquitin-like domain
- SH2 domain
- Tyrosine-protein kinase, non-receptor, TYK2, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TYK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TYK2 as an antibody target. Whether an autoantibody or antibody against TYK2 could matter depends on whether native TYK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TYK2 is annotated at the cell surface, where native TYK2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TYK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...